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SUMMARY 
We report that tumor cells devoid of their mitochondrial genome (mtDNA) show 
delayed tumor growth and that tumor formation is associated with acquisition of 
mtDNA from host cells. This leads to partial recovery of mitochondrial function in 
cells derived from primary tumors grown from cells without mtDNA and a shorter 
lag in tumor growth. Cell lines from circulating tumor cells showed further recovery 
of mitochondrial respiration and an intermediate lag to tumor growth, while cells 
from lung metastases exhibited full restoration of respiratory function and no lag in 
tumor growth. Stepwise assembly of mitochondrial respiratory supercomplexes was 
correlated with acquisition of respiratory function. Our findings indicate horizontal 
transfer of mtDNA from host cells in the tumor microenvironment to tumor cells 
with compromised respiratory function to re-establish respiration and tumor-
initiating efficacy. These results suggest a novel pathophysiological process for 
overcoming mtDNA damage and support the notion of high plasticity of malignant 
cells. 
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INTRODUCTION 
Mitochondria are structurally dynamic organelles with a circular genome (mtDNA) of 
~16.5 kb in mammals, encoding 13 subunits of the respiratory complexes (RCs), 22 
tRNAs and two rRNAs. Cells contain discreet and networked mitochondria, each with 
multiple mtDNA copies. The mitochondrial proteome comprises ~1,500 proteins, the vast 
majority of which are encoded by nuclear DNA (nDNA) (Neupert and Herrmann, 2007; 
Wallace, 2012). Of importance for the replication and transcription of mtDNA is the 
regulatory D-LOOP, which binds the mitochondrial transcription factor TFAM and other 
regulatory proteins (Falkenberg et al., 2007). A major role of mitochondria, generation of 
ATP, is facilitated by oxidative phosphorylation (OXPHOS) comprising four complexes 
of the electron transport chain (ETC), complex I (CI), CII, CIII and CIV, and CV with 
ATP synthase activity. RCs form supercomplexes (SCs), such as the respirasome 
(Schägger and Pfeiffer, 2010; Acin-Perez et al., 2008; Althoff et al., 2011) that transfers 
electrons from CI to CIV via CIII (Lapuente-Brun et al., 2013). RCs and SCs are 
assembled stepwise in a process involving specific factors (Moreno-Lastres et al., 2012; 
Lapuente-Brun et al., 2013; Ikeda et al., 2013). 
Due to the central role of mitochondria in homeostasis, cells have conserved 
control systems to maintain mitochondrial integrity, appropriate mitochondrial mass, and 
bioenergetic and metabolic functions. In many pathologies, mtDNA mutations affect 
tissues with high demand for energy (Krishnan et al., 2008; Lu et al., 2009; Schon et al., 
2012; Wallace, 2012). Cancer is characterized by altered energy metabolism 
(DeBarardinis et al 2007, Kroemer and Pouyssegur, 2008; Vander Heiden et al., 2009; 
Ralph et al., 2010; Hanahan and Weinberg, 2011) involving not only genetic alterations 
in nDNA, but also mtDNA mutations and changes in mtDNA copy number (Surani, 
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2001; Wallace and Fan, 2010; De Carvalho, 2010; Plass et al., 2013). Certain mtDNA 
mutations compromise ETC function and contribute to a shift to aerobic glycolysis that 
typifies metastatic progression (Ishikawa et al., 2008; Ralph et al., 2010). Relevant 
studies are limited by the difficulty of experimentally manipulating mtDNA of tumor 
cells and the paucity of tumor models with mtDNA mutations. A model of severe 
mtDNA damage involves mitochondrial genome deletion (King and Attardi, 1988). 
These ρ0 cells grow in culture with uridine and pyruvate supplementation, but the 
question whether they can form tumors following autologous transplantation has not been 
investigated. 
We have developed two stable murine tumor cell models lacking mtDNA and 
investigated the ability of these cells to form tumors in syngeneic mice. Our results show 
delayed tumor growth and acquisition of mtDNA from host cells. Cells derived from 
primary tumors that grow from ρ0 cells and from their circulating and metastatic 
counterparts progressively recovered mitochondrial respiratory function, and this was 
associated with assembly of mitochondrial SCs and correlated with tumorigenicity. 
 
RESULTS 
Tumor Cells Devoid of mtDNA Show Delayed Tumor Growth 
To simulate severe mitochondrial genome damage, we deleted mtDNA in metastatic 
murine B16 melanoma and 4T1 breast carcinoma cells using low-dose EtBr, thereby 
generating B16ρ0 and 4T1ρ0 cells that have been maintained as stable auxotrophic cell 
lines in the absence of EtBr for more than two years. When injected subcutaneously (s.c.) 
into groups of 5 syngeneic C57BL/6 (n=3) or NOD/scid (n=1) mice, B16ρ0 cells (105) 
initiated tumors with a delay of more than 20 days compared to parental cells (Figure 
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1A). Intravenous (i.v.) injection of B16ρ0 cells into NOD/scid mice failed to generate 
lung tumors, whereas cell lines derived from s.c. tumors and from lung metastases that 
grew from B16ρ0 cells following long-term culture formed lung tumors at a similar 
frequency to B16 cells (Figure 1A). These cell lines were shown to be of B16 rather than 
host origin because they produced melanin under stress. Similarly, 4T1ρ0 cells that are 6-
thioguanine (6TG)-resistant formed tumors with a lag of 20-25 days when 105 cells were 
injected s.c. (n=6) or orthotopically into the mammary fat pad (n=1) of Balb/c mice, but 
failed to form lung tumors following i.v. injection (Figure 1B) or following s.c. injection 
of ≤104 cells (Figure S1). 
Using 6TG selection, cell lines were derived from primary tumors that formed from 
4T1ρ0 cells (4T1ρ0SC), from circulating tumor cells (4T1ρ0CTC) and lung metastases 
(4T1ρ0SCL). When injected i.v, both 4T1ρ0SC and 4T1ρ0SCL cells, and a cell line 
derived from lung metastases that formed from an orthotopic tumor (4T1ρoMFPL cells), 
formed lung tumors that were comparable to 4T1 cells (Figure 1B). When injected s.c. 
into Balb/c mice, 4T1ρ0SC cells formed tumors with a delay of ~10 days, whereas 
4T1ρ0SCL cells initiated tumors without a lag (Figure 1C, n=2). 4T1ρ0CTC formed 
tumors with a lag between that of 4T1ρ0SC and 4T1ρ0SCL cells. 
To investigate whether acquisition of tumorigenic properties was associated with 
respiratory competence, tissue from tumors that formed from each cell line were assessed 
by high-resolution respirometry. Relative to cells from parental tumors, respiration by 
tumors that grew from 4T1ρ0 cells was reduced by 60% whereas 4T1ρ0SC, 4T1ρ0CTC 
and 4T1ρ0SCL cell-derived tumors exhibited progressive recovery of respiration (Figure 
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1D). Histological examination of tumors derived from each cell line showed qualitative 
similarities (Figure 1E). 
 
Tumors Derived from ρ0 Cells Contain Host mtDNA and Exhibit Functional 
Mitochondrial Protein Synthesis 
PCR analysis of the mtDNA-encoded Cytb gene revealed no product in B16ρ0 or 4T1ρ0 
cells (Figure 2A). Because ρ0 cells contain nuclear mitochondrial DNA sequences 
(NUMTs) and mitochondrial pseudogenes, these results exclude a significant contribution 
from these sources. Unexpectedly, Cytb was present in B16ρ0SC and B16ρ0SCL cells. 
Similar results were obtained with 4T1ρ0SC and 4T1ρ0SCL cells (Figure 2A). To 
establish the host origin of this mtDNA and to exclude the presence of latent mtDNA in 
ρ0 cells, we sequenced the polymorphic mitochondrial tRNAArg locus. Cells from both 
B16ρ0- and 4T1ρ0-derived tumors showed the polymorphism of the host mouse (Bayona-
Bafaluy et al., 2003) (Figure 2B), establishing transfer of mtDNA from host cells in the 
tumor microenvironment (8 consecutive adenines for C57BL/6 and 9 for NOD/SCID and 
Balb/c mice) to ρ0 tumor cells in each model. To further confirm the host origin of 
mtDNA, we sequenced whole mtDNA from B16, B16ρ0SC, 4T1 and 4T1ρ0SC cells 
(Table S1), and identified one additional polymorphism in Nd4 (site 10335) of B16 and 
B16ρ0SC cells, and two additional polymorphisms in 16SrRNA (site 1576) and D-Loop 
(site 16076) of 4T1 and 4T1ρ0SC cells, confirming the host origin of mtDNA in tumors 
derived from B16ρ0 and 4T1ρ0 cells. Mitochondrial protein synthesis was shown to be 
functional in cell lines derived from tumors from B16ρ0 and 4T1ρ0 cells by the presence 
of COI, a mtDNA-encoded protein (Figure 2C). 
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Distinct Phenotypic Properties and Mitochondrial Morphology of 4T1ρ0 Cells 
Following mtDNA Acquisition 
Acquisition of host mtDNA by ρ0 tumor cells prompted us to investigate the phenotypic 
and morphological properties of 4T1ρ0-derived sublines, i.e. 4T1ρ0SC, 4T1ρ0CTC and 
4T1ρ0SCL cells. We also investigated ‘matching’ cells derived from s.c. tumors (4T1SC 
cells) and lung metastases (4T1SCL cells) that grew from the parental 4T1 cells. The 
doubling times of these cell lines were: 4T1, 18.7 h; 4T1SC, 17.5 h; 4T1SCL, 16 h; 
4T1ρ0, 33.6 h; 4T1ρ0SC, 21.5 h; 4T1ρ0CTC, 23.1 h; and 4T1ρ0SCL, 16.1 h. Light 
microscopy revealed morphological differences of individual sublines (Figure 3A). 
Staining with EtBr confirmed the absence of mtDNA in 4T1ρ0 cells, although nucleolar 
staining was evident. Co-staining with MitoTracker Red showed high mtDNA 
heterogeneity in 4T1ρ0SC and to a lesser extent, in 4T1ρ0CTC cells. Flow cytometric 
analysis revealed that ~60% of 4T1ρ0SC cells contained little or no mtDNA, while 
almost 90% of 4T1ρ0CTC and 100% of 4T1ρ0SCL cells contained mitochondria with 
DNA (Figure 3B). 4T1SC cells showed similar mtDNA staining to that found in 4T1 and 
4T1SCL cells (Figure S2A).  
We tested individual sublines for their autophagic status, reasoning that 4T1ρ0SC 
cells may exhibit higher mitophagy to remove respiration-defective mitochondria devoid 
of mtDNA. Initial acridine orange (AO) staining showed heterogeneous acidic vesicles in 
4T1ρ0SC cells, while western blotting (WB) revealed lower levels of the autophagy 
marker LC3B-II in 4T1ρ0 and 4T1ρ0SC cells than in 4T1ρ0CTC and 4T1ρ0SCL cells, 
and higher levels of p62 in 4T1ρ0SC cells, both with control cells and cells treated with 
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the autophagy inhibitor, bafilomycin A1 (Figure 3C). The mitophagy marker, Parkin, 
showed increased expression in cells derived from 4T1ρ0 and highest expression in 
4T1ρ0SCL cells, but BNIP3 expression remained unaltered in the sublines. Since 
individual sublines are derived from different stages of metastatic tumor progression, we 
investigated the markers of epithelial-mesenchymal transition (EMT), E-cadherin and 
vimentin. Figure 3D shows that the sublines differed coordinately in the level of 
expression of these markers, consistent with their different origin. 
Investigation of mitochondrial morphology by transmission electron microscopy 
(TEM) with statistical analysis of cristae revealed that mitochondria of 4T1ρ0 cells were 
distended with low-density internal staining, and were largely free of stacked cristae but 
contained ring-like cristae (Figure 4). Intriguingly, 4T1ρ0SC cells showed mitochondria 
with and without cristae while 4T1ρ0CTC cells contained more mitochondria with 
cristae. 4T1ρ0SCL cells were indistinguishable from parental 4T1 cells and the 
‘matching’ 4T1SC tumor cells (Figures 4, S2B). 
 
Bioenergetics and Mitochondrial Function Following mtDNA Acquisition 
Cells devoid of mtDNA use glycolysis as a source of ATP. Compared with parental 4T1 
cells, 4T1ρ0, 4T1ρ0SC and 4T1ρ0CTC cells showed elevated glucose uptake and 
increased production of lactate, and lower levels of ATP (Figure 5A-C), In contrast, 
4T1ρ0SCL cells were less glycolytic and more similar to parental 4T1 cells, as were the 
‘matching’ sublines (Figure S3A-C). Cellular bioenergetic status and the efficiency of 
mitochondrial respiration modulate production of reactive oxygen species (ROS). We 
used the mitochondrially targeted probe, MitoSOX, to evaluate mitochondrial superoxide 
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generation. Cell lines from primary tumors that developed from 4T1ρ0 cells when 
injected s.c. or into the mammary fat pad showed distinct intermediate and high 
fluorescence intensity peaks, while cells from lung metastases showed predominantly a 
high fluorescence intensity peak comparable with parental 4T1 cells (Figure S4A). With 
4T1ρ0 cells, only the intermediate peak was present. Similar results were obtained with 
B16 cells (Figure S4B). Quantitation of MitoSOX staining showed low fluorescence in 
4T1ρ0 cells with other sublines being comparable with parental 4T1 cells (Figure 5D). 
Dihydrodichlorofluorescein (DCF) measurement of cytosolic hydrogen peroxide showed 
non-significant reduction in the signal in 4T1ρ0, 4T1ρ0SC and 4T1ρ0SCL cells relative to 
parental 4T1 cells (Figure 5E). Using TMRM as a probe, mitochondrial membrane 
potential (∆Ψm) was found to be similar in 4T1and 4T1ρ0 cells, elevated in 4T1ρ0SCL 
and to a lesser extent in 4T1ρ0SC cells, and was greatly reduced in 4T1ρ0CTC cells 
(Figure 5F). 
 
Respiration Recovery Following mtDNA Acquisition by 4T1ρ0 Cells 
4T1ρ0 cells showed barely detectable respiration, which was low in 4T1ρ0SC cells and 
higher in 4T1ρ0CTC cells, while 4T1ρ0SCL cells respired at a rate similar to that of 
parental cells (Figures 5G and S5A). Respiration was similar in 4T1 and 4T1SC cells and 
slightly lower in 4T1SCL cells (Figure S3F). Respiration via CI and CII was very low in 
4T1ρ0SC cells and higher in 4T1ρ0CTC cells. Respiration via CI was similar in parental 
cells and 4T1ρ0SCL while respiration via CII was highly elevated in metastatic cells 
(Figures 5H and S5B). A similar respiration profile was found for isolated mitochondria 
(Figure S5C), indicating that respiration of the sublines is primarily governed by 
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mitochondria and not the extra-mitochondrial compartment. Collectively, these results 
show significant differences in respiration of individual 4T1ρ0-derived sublines, which 
paralleled the efficacy of these cells to initiate tumor growth (Figure 1C). 
 
mtDNA Recovery and Transcription Following mtDNA Acquisition 
To determine whether phenotypic differences in 4T1ρ0-derived sublines following 
mtDNA acquisition were related to gradual restoration of mtDNA, we evaluated the 
mtDNA/nDNA ratio. While 4T1ρ0 cells did not contain mtDNA, we found a several-fold 
increase in the mtDNA/nDNA ratio in 4T1ρ0SC cells compared with parental cells. This 
high ratio was maintained over several months of the cells in culture (Figure 6A). 
4T1ρ0CTC and 4T1ρ0SCL cells showed ratios more similar to those of parental cells as 
did the ‘matching’ 4T1SC and 4T1SCL cells (Figure S3G). No transcripts of mtDNA-
encoded genes were found in 4T1ρ0 cells, but these were transcribed in 4T1ρ0-derived 
sublines. Relative to 4T1 cells Nd1, Nd2, Nd4, Nd4l, Nd5, Nd6 and mt-Co2 were elevated 
2-4-fold in 4T1ρ0SC cells, and Nd1, Nd2, mt-Co2, Atp6 and Atp8 elevated 1.5-4.5-fold in 
4T1ρ0SCL cells. The level of the D-loop transcript was similar in all 4T1ρ0-derived 
sublines, indicating that the regulatory region of mtDNA does not hinder mtDNA 
replication or transcription in these cells (Figure 6B). 
Nuclear DNA-encoded subunits of mitochondrial complexes, with the exception of 
Sdhc, showed a similar expression pattern across the cell lines, indicating a common 
mechanism regulating their transcription (Figure 6C). Of the regulatory genes, the 
relative level of mRNA for the mitochondrial transcription factor, Tfam, was very low in 
4T1ρ0, and almost 3-fold higher in 4T1ρ0SC cells, but similar to 4T1 cells in 4T1ρ0CTC 
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and 4T1ρ0SCL cells (Figure 6D). The Tfam transcript profile in the sub-lines mirrors the 
mtDNA/nDNA ratios, suggesting a causal relationship. Nrf1, Nrf2, Tfb1m, Tfb2m and 
Top1m transcripts were depressed in 4T1ρ0SC cells, while the assembly factor Scafi 
(Cox7a2l) was decreased in 4T1ρ0, 4T1ρ0SC and 4T1ρ0CTC cells, and the assembly 
factor Hig2a was relatively unchanged. No differences in these transcripts were observed 
in the ‘matching’ cells (Figure S3H). 
 
Mitochondrial Protein Synthesis, and Citrate Synthase (CS) and CII Activity 
Following mtDNA Acquisition 
We next studied translation of mtDNA-encoded proteins. Figure 7A shows only 
background staining in 4T1ρ0 cells, with the proteins coordinately translated 2-3-times 
more efficiently in the other sublines compared with parental cells. Activity of CS, the 
first enzyme of the TCA cycle, was increased 2.5-fold in 4T1ρ0 and 4T1ρ0SC cells, while 
in 4T1ρ0CTC and 4T1ρ0SCL cells the activity was similar to that in parental cells (Figure 
7B). This increase was not observed in the ‘matching’ sublines (Figure S3I). We did not 
see a major difference in succinate dehydrogenase (SDH) activity in sublines derived 
from 4T1ρ0 cells (Figure 7C) or the ‘matching’ cells (Figure S3J). Succinate quinone 
reductase (SQR) activity of CII was very low in 4T1ρ0, 4T1ρ0SC and 4T1ρ0CTC cells, 
while in 4T1ρ0SCL cells it was 70% higher than in 4T1 cells (Figure 7D). SQR activity 
was about 2-fold higher in the metastatic 4T1SCL cells than in 4T1 and 4T1SC (Figure 
S3K). 
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Respiratory Complex Assembly and Subunit Expression Following mtDNA 
Acquisition 
To determine the steady-state level of proteins representing subunits of RCs encoded by 
mtDNA and nDNA, as well as proteins with a regulatory or more general role in 
mitochondria, we performed WB following SDS-PAGE on 4T1ρ0-derived and parental 
cells (Figure 7E and S3L). The nDNA-encoded CI subunits NDUFS3 and NDUFA9 were 
not expressed in 4T1ρ0 cells but were expressed in all other cell lines. The CII subunit 
SDHA was highly expressed in all cell lines while SDHB was less highly expressed in 
4T1ρ0, 4T1ρ0SC and 4T1ρ0SCL cells. The assembly factor SDHAF2 that flavinates 
SDHA was expressed in all cell lines but more strongly in 4T1ρoSC cells, while the 
nuclear-encoded CIII protein, Core2, was expressed in all sulines but was lower in 4T1ρ0 
cells. The nuclear-encoded CV protein, ATPaseβ, was expressed similarly in all sublines. 
The mtDNA-encoded COI and nDNA-encoded COIV subunits of CIV were not 
expressed in 4T1ρ0 cells with COI being highest in 4T1ρ0SC cells. nDNA-encoded 
proteins that are not part of RCs were expressed in all sub-lines with Cyt c being 
particularly high in 4T1ρ0 cells, and TIM23 and VDAC1 attenuated in these cells. 
PGCα/β that regulates the transcription factors NRF1/NRF2 was poorly expressed in 
4T1ρ0 cells. OPA1, which modulates cristae formation and geometry, was low in 4T1ρ0 
and 4T1ρ0SC cells, and progressively increased in 4T1ρ0CTC and 4T1ρ0SCL cells, while 
it was high in ‘matching’ 4T1SC and 4T1SCL cells (Figure S3L). 
Native blue gel electrophoresis (NBGE) using a mild detergent followed by WB 
was employed to assess the assembly of individual RCs and SCs (Figure 7F). Parental 
cells showed a high level of the fully assembled respirasome (CI+CIII2+CIVn), which 
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was absent in 4T1ρ0 cells. Low respirasome levels were observed in 4T1ρ0SC cells and 
4T1ρ0CTC cells, and full restoration was observed in 4T1ρ0SCL cells. Free CI, CIII in 
the form of a dimer and in an SC with CIV, and CIV largely in the form of a monomer, 
were present at similar levels in all cell types except for 4T1ρ0 cells. CV was partially 
assembled in 4T1ρ0 cells due to the absence of structural mtDNA-encoded ATP6 and 
ATP8, while it was fully assembled and present as a dimer in all other cell types. CII was 
represented in 4T1ρ0 cells by the highly expressed SDHA subunit. SDHB, only observed 
in fully assembled CII, was lower in 4T1ρ0, 4T1ρ0SC and 4T1ρ0CTC than in 4T1 cells 
and elevated by 70% in 4T1ρ0SCL cells. These findings document that transition from 
4T1ρ0CTC to 4T1ρ0SCL cells yields a fully assembled respirasome and CII, associated 
with efficient respiration and tumor initiation. 
 
DISCUSSION 
Whole genome approaches have deepened to our understanding of the role of mutations 
in nDNA in different cancers (Kandoth et al., 2013; Khurana et al., 2013). Mutations in 
mtDNA have also been described in cancer, but their contribution to tumor initiation, 
progression and metastasis is less clear (Brandon et al., 2006; Wallace, 2012; Schon et 
al., 2012). Functionally relevant mtDNA mutations may be expected to compromise 
mitochondrial respiration and promote aerobic glycolysis, a bioenergetic trait of many 
tumors. In breast cancer, mtDNA mutations and low mtDNA copy number are associated 
with increased metastasis and poor prognosis (Petros et al., 2005, Tseng et al., 2006), 
while a recent study showed that low mtDNA copy number promotes metastasis by 
inducing EMT via mitochondrial retrograde signaling (Guha and Avadhani, 2013). 
-14- 
Using highly metastatic murine tumor models with mtDNA deletion to simulate 
severe mtDNA damage, we have found a long lag to tumor formation for both B16ρ0 
melanoma and 4T1ρ0 breast carcinoma cells in C57BL/6 and Balb/c mice respectively, as 
well as in the NOD/scid animals. Previous reports on grafting human ρ0 tumor cells have 
provided variable results, depending on the tumor type, the site of injection and the 
recipient (Hayashi et al., 1992; Morais et al., 1994; Cavelli et al., 1997; Magda et al., 
2008; Kulaweic et al., 2008; Imanishi et al., 2011). In both our models, delayed tumor 
growth was observed, and was associated with mtDNA acquisition from the host 
suggestive of horizontal mtDNA transfer. This was demonstrated when cells derived 
from tumors that grew from B16ρ0 and 4T1ρ0 cells were found to be positive for both the 
Cytb gene and COI protein. We excluded the possibility of latent mtDNA being present 
in ρ0 cells by showing that tumors growing from B16ρ0 and 4T1ρ0 cells contained the 
tRNAArg gene polymorphism of the host mouse (Bayona-Bafaluy et al., 2006) which is 
distinct from that of the original tumor. This notion is corroborated by our identification 
of additional polymorphisms in B16ρ0SC and 4T1ρ0SC cells that are identical with the 
host and distinct from parental cells, which, when taken together with the tRNAArg 
polymorphism unequivocally prove the host origin of the mtDNA. 
Because there is no known mechanism for intercellular transfer of mtDNA across 
both mitochondrial inner and outer membranes and the plasma membrane, transfer of 
whole mitochondria is the most likely explanation. This has previously been shown to 
occur in vitro (Spees et al., 2006; Cho et al., 2012; Gerdes and Carvalho, 2008; Gurke et 
al., 2008) and in a mouse model of acute lung injury, documenting mitochondrial transfer 
from mesenchymal stem cells (MSCs) injected into the animal’s lungs (Islam et al., 
2012). Organelle transfer between cells has been reviewed recently, with a number of 
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reports documenting mitochondrial transfer (Rogers and Bhattacharya, 2013). 
Phylogenetic evidence also supports mtDNA transfer between cells as shown in a 
transmissible canine venereal tumor (Rebbeck et al., 2011). 
To better understand the role of mitochondrial respiration in tumorigenesis and 
metastasis, we characterized malignant cells from different tumor microenvironments in 
the 4T1ρ0 tumor model. To ensure that the results relate to mtDNA acquisition and not 
local microenvironment effects, we isolated ‘matching’ cell lines from primary s.c. 4T1 
tumors and from lung metastases. Of interest was the finding that cells derived from 
primary tumors that grew from 4T1ρ0 cells still exhibited a considerable delay in tumor 
initiation, while the kinetics of growth of tumors derived from the metastatic 4T1ρ0SCL 
cells showed no delay in tumor initiation. These findings, initially acquired in our 
laboratory in Wellington, New Zealand, were repeated with almost identical results in our 
other laboratory in Prague, Czech Republic, 9 months later, indicating the robust nature 
of the results and their high reproducibility. 
The most striking finding is the stepwise recovery of mitochondrial respiration from 
undetectable levels in ρ0 cells to low levels in primary tumor cells derived from ρ0 cells, 
progressing to higher levels of respiration in CTCs and full restoration in metastatic cells. 
The phenotype of the individual cell types was maintained in culture, as documented by 
sustained high mtDNA/nDNA ratio in cells from the primary tumor. This suggests that 
these cells are unable to restore full mitochondrial function during long-term maintenance 
in vitro and need microenvironmental exposure to progress to full respiratory 
competence. Our findings are consistent with earlier in vitro results (Spees et al., 2006) 
showing that mitochondrial transfer from MSCs and skin fibroblasts to human A549ρ0 
lung adenocarcinoma cells restored their respiratory capacity. 
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We provide detailed analysis of the individual stages of recovery of respiratory 
competence from parental cells to their metastatic counterparts, documenting each 
‘recovery’ stage. We show that a crucial step of full respiration recovery is associated 
with the assembly of the respirasome and CII, with SDH activity being a component of 
the TCA cycle as well as OXPHOS that is compromised in ρ0 cells. This is also 
supported by the high level of SQR activity in metastatic cells. Our results show that the 
level of the assembly factor SCAFI (Lapuente-Brun et al., 2013), but not HIG2A 
(Moreno-Lastres et al., 2012), correlates with the extent of respirasome assembly in 
tumors derived from 4T1ρ0 cells. The key regulatory role of SCAFI and other 
respirasome assembly factors in the tumor microenvironment in metastatic progression 
needs further investigation. Similarly, the reasons for full assembly of CII in metastatic 
cells are not known but are likely to be linked to retrograde mitochondrial signaling. That 
assembly of the RCs and SCs is crucial for the full recovery of mitochondrial respiration 
is evidenced by our findings that except for ρ0 cells, sublines of these cells exhibited 
transcriptional and translational activity of mtDNA-encoded genes, with fully-assembled 
CI, CIII and CIV being present. A key to understanding the different behaviors of the 
sublines may relate to the high level of mitochondrial heterogeneity. 
Our findings raise several challenging questions. A fundamental one relates to how 
ρ0 cells, having acquired mtDNA, progress from primary tumor via the circulation to 
lung metastases, and how this progression leads to full recovery of respiration. In our 
model, metastatic potential is encoded in the nuclear genome but suppressed by the 
absence of mtDNA. Acquisition of ‘normal’ mtDNA from the microenvironment enables 
4T1ρ0 cells to grow as primary tumors and to ‘unleash’ their metastatic potential. It is 
possible that rare cells acquire one or a few mitochondria that contain mtDNA and that 
-17- 
these cells replicate their mtDNA, build cisternal structures of cristae and multiply 
clonally at the expense of cells lacking mtDNA that are progressively eliminated by 
autophagy. Our finding that autophagic activity is low in 4T1ρ0 and 4T1ρ0SC cells that 
also have very low respiration is consistent with a report showing faulty autophagy in 
cells with suppressed ETC (Graef and Nunnari, 2011). Such cells do not appear to ‘clear’ 
malfunctional mitochondria, which is more likely to occur at the stage of CTCs, where 
respiration is partially restored and autophagy is higher. 
Quantification of mtDNA/nDNA ratios showed stable elevation in 4T1ρ0SC cells, 
consistent with high levels of TFAM, a factor critical for replication, transcription and 
packaging of mtDNA (Kukat and Larsson, 2013). Compromised respiration is correlated 
with lack of cristae in all 4T1ρ0 cells and poorly formed cristae in many 4T1ρ0SC cells, 
consistent with low OPA1 levels (Cogliati et al., 2013). The reasons why ρ0 cells that 
have acquired mtDNA require conditioning by their local microenvironment to restore a 
parental intracellular distribution of mtDNA are not clear, but may relate to progressive 
changes in mitochondria-to-nucleus retrograde signaling that eventually normalizes both 
mtDNA distribution and respiratory function. The importance of the tumor 
microenvironment is corroborated by the finding that 4T1 cells show both epithelial and 
mesenchymal markers, highly localized within the cell and exhibiting different patterns 
of compartmentalization, with coordinate changes in E-cadherin and vimentin staining 
across 4T1 cells and derived sublines confirming the different origins of the individual 
4T1 sublines. 
The signals that ρ0 cells employ to acquire mtDNA from stromal cells as well as 
how this process occurs are unclear. It has been proposed that cells form tunneling 
nanotubes to move biomaterial between cells (Rustom et al., 2004; Gerdes and Carvalho, 
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2008), as shown for the mobilization of organelles (Rustom et al., 2004; Koyanagi et al., 
2005; Lou et al., 2012; Islam et al., 2012; Pasquier et al., 2013); this process is 
suppressed by cytochalasin B (Bukoreshtliev et al., 2009). Other mechanisms of 
organelle trafficking between cells have also been proposed including membrane 
vesicles, cell fusion and various other cytoplasmic bridging processes. Of importance is 
the minimum level of mtDNA damage needed to initiate intercellular transfer of 
functional mitochondria. It has been shown that a gradual decrease in the number of 
mtDNA copies in human glioblastoma cells eventually results in a phenotype unable to 
recover in vitro, while injecting these cells into immunocompromized mice resulted in 
delayed formation of tumors and restoration of mitochondrial function (Dickinson et al., 
2013). Another important question is how recovering mitochondria signal to the nucleus 
to trigger transcription of genes needed for mitochondrial function. Retrograde 
mitochondrial signaling is poorly understood at present and may include the bioenergetic 
status of the cell (e.g. the AMP/ATP ratio), the level of ROS, release of metabolites, 
Ca2+, etc (Liu and Butow, 2006; Moreno-Loshuertos et al., 2006; Ryan and Hoogenraad, 
2007, Guha and Avadhani, 2013). 
In conclusion, we have shown that tumor cells devoid of mtDNA, a model of 
extensive mtDNA damage, can acquire mtDNA of host origin, resulting in stepwise 
recovery of respiration from primary to metastatic tumor cells. We show that a crucial 
aspect of full recovery of mitochondrial respiration is full assembly of the respirasome 
and CII, which are directly linked with efficient tumor formation. To our knowledge, this 
is the first report of in vivo mitochondrial genome acquisition by tumor cells with 
compromised respiration due to mtDNA deletion, and demonstrates that mitochondrial 
respiration is required for tumorigenesis in these autologous models. Mitochondrial DNA 
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mutations can also contribute to tumorigenesis, suggesting that optimum bioenergetic 
balance may relate to the individual tumor (Tan et al., 2013). Our results support the 
notion of tumor plasticity and involving exceptional ability to overcome unfavorable 
situations (Hanahan and Weinberg, 2011). 
 
EXPERIMENTAL PROCEDURES 
Cell Culture, Tumor Formation and Establishment of Tumor-Derived Cells. B16 
and 6TG-resistant 4T1 cells (Tan and Berridge, 2004) from ATCC were used. Cell 
maintenance, preparation of ρ0 cells and the establishment of tumors and tumor-derived 
cell cultures are described in detail in the Supplementary Text. 
Mitochondria Isolation and Sequence Analysis  
Functional mitochondrial were isolated according to Schmitt et al (2013) and mtDNA 
tRNAArg sequencing carried out on a PCR-amplified region using Sanger sequencing. 
Whole mtDNA sequencing used overlapping PCR amplified products and both Ion 
Torrent and Nanopore MinION approaches. 
Microscopic and Flow Cytometric Cell Evaluation. Standard methodology described 
in more detail in the Supplementary Text was used for bright field and fluorescence 
microscopy and TEM, while flow cytometry used a BD FACScalibur. 
Respiration Assays. Cellular respiration was evaluated using an Oxygraph-2k instrument 
(Oroboros Instruments) and published procedures (Pesta and Gnaiger, 2012), as detailed 
in the Supplementary Text. 
Mitochondrial Biochemistry Assays and Gene Expression Analysis 
Mitochondrial membrane potential and ROS production were measured by flow 
cytometry using the fluorescent probes TMRM, DCF-DA and MitoSOX. Glucose uptake 
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was measured using 2-NGDG, ATP using a luciferase-based assay and lactate 
colorimetrically.  Cytb was measured by PCR product, while gene expression analysis 
used qRT-PCR. Western blotting and NBGE used well-established methods while newly-
synthesisized mitochondrial proteins were evaluated using a Clik-iT AHA kit followed 
by Western blotting. 
Statistical Analysis. Unless stated otherwise, data are mean ± S.D of at least three 
independent experiments or used groups of 5 mice. The two-tailed unpaired Student’s t 
test was used to assess statistical significance with p<0.05 being regarded as significant. 
Images are representative of three independent experiments. For TEM data, Tukey’s 
multiple comparison procedure and statistical test was used at p<0.05. 
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FIGURE LEGENDS 
Figure 1. Tumor Cells lacking mtDNA Show Delayed Tumor Growth (A) B16 and 
B16ρ0 cells (105) were injected s.c. into C57BL/6 or NOD/scid mice and tumor growth 
monitored. These cells, and cell lines derived from s.c. tumors and lung metastases that 
grew from B16ρ0 cells were also injected i.v. into NOD/scid mice, and lung weight and 
tumor colonies determined. (B) 4T1 and 4T1ρ0 cells were injected s.c. or orthotopically 
into the mammary fat pad of Balb/c mice and tumor growth monitored. These cells and 
6TG-resistant cell lines derived from s.c. tumors and lung metastases that grew from 
4T1ρ0 cells were also injected i.v. into Balb/c mice and lung weight and tumor colonies 
determined. Images of lungs from these mice are also shown. (C) 4T1, 4T1ρ0, 4T1ρ0SC, 
4T1ρ0CTC and 4T1ρ0SCL cells were injected into Balb/c mice and tumor growth 
monitored. (D) Oxygen consumption by tissue of tumors derived from cells as stated 
above (C) was compared with respiration of liver tissue obtained from the same mice. (E) 
Histological staining of tissue sections from (C) stained with H & E; size bar 20 µm. The 
data are derived from three independent experiments and the results expressed as mean 
values ± S.D. The symbol ‘*’ documents significantly significant differences with p<0.05 
and ‘***’ p<0.001. 
 
Figure 2. Tumors Derived from mtDNA-Deficient Cells Contain mtDNA of Host 
Origin. (A) Left panels: Cytb PCR analysis of B16, B16ρ0 and B16ρ0SC and B16ρ0SCL 
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tumor sub-lines from C57BL/6 (upper left panel) and NOD/scid mice (lower left panel). 
Right panels: Cytb PCR analysis of 4T1, 4T1ρ0 and tumor sub-lines from orthotopic 
primary and metastatic tumors (upper right panel, 4T1ρ0MFP, 4T1ρ0MFPL) and s.c. 
primary and metastatic tumor (4T1ρ0SC, 4T1ρ0SCL) that form in Balb/c mice. (B) Left 
panels: sequence analysis of the polymorphic region (9817-9836 C57BL/6 reference 
NC_005089.1) of the mitochondrial tRNAArg gene from C57BL/6 and NOD/scid mice and 
from subcutaneous tumors derived from B16ρo cells grown in C57BL/6 and NOD/scid 
mice. Right panels: comparable sequence analysis of the mitochondrial tRNAArg gene 
from Balb/c mice and from a subcutaneous tumor derived from 4T1ρ0 cells grown in 
Balb/c mice. A summary Table of the results is presented. (C) COI immunocytochemical 
staining (green) of parental, ρ0 and individual sub-lines of B16 and 4T1 cells. Nuclei 
were stained with Hoechst 33342 (blue). Size bar, 10 µm. 
 
Figure 3. Individual Cell Types Differ in Their Phenotype and Mitochondrial 
Morphology. (A) 4T1 and the derived sub-lines were evaluated using light microscopy. 
(B) The sub-lines were stained with EtBr and MitoTracker Red, and evaluated by 
confocal microscopy for yellow (EtBr) and red fluorescence (MitoTracker Red). Nuclei 
were stained with Hoechst 33342. The cells were evaluated using flow cytometry for the 
percentage of mitochondria with (upper right quadrant) and without (left quadrants) 
DNA. (C) The sub-lines were incubated with AO (red) to visualize acidic vacuoles and 
with Hoechst 33342 to show nuclei (blue). Cells were also probed by WB for LC3B-I/II, 
p62, Parkin and BNIP3 with actin as the loading control. Bafilomycin A treatment (20 
µM, 16 h) was included in the LC3BII analysis to determine autophagic flux. (D) The 
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sub-lines were incubated with E-cadherin (green) and vimentin (red) and counterstained 
with Hoechst 33342 (blue), and inspected by confocal microscopy. 
 
Figure 4. TEM Analysis of Individual Sub-lines Shows Mitochondrial 
Ultrastructural Differences. 4T1 cells and the derived sub-lines were grown on cover 
slips, processed for TEM as detailed in Materials and Methods, and examined using 
TEM. The bar indicates 500 nm for the general cell view and 200 nm for the magnified 
mitochondrial image. The lower graphs indicate percent mitochondria with visible cristae 
(left) and percent mitochondria with ring-like cristae (right) for each of the 4T1ρ0 sub-
lines. The percentage of mitochondria with visible cristae in 4T1 cells was set as 100%, 
the percentage of mitochondria with ring-like cristae in 4T1ρ0 cells set as 100%. The data 
are derived from three independent experiments and the results expressed as mean values 
± S.D. The symbol ‘*’ documents significantly significant differences with p<0.05. 
 
Figure 5. Bioenergetic Properties of 4T1 Cell Types. 4T1 cells and the derived sub-
lines were assessed for glucose uptake (A), lactate production (B) and the level of ATP 
(C). Mitochondrial superoxide production was evaluated using MitoSOX (D), cytosolic 
hydrogen peroxide with DCF (E) and ∆Ψm using TMRM (F). (G) Cells were evaluated 
for routine, leak, net (R-L) and uncoupled (ETS) respiration using the Oxygraph 
respirometer as described in more detail in Materials and Methods and in the Legend to 
Figure S3A. (H) Cells were permeabilized with digitonin and evaluated for respiration at 
the presence of substrates specific for CI and CII. The data are derived from three 
independent experiments and the results expressed as mean values ± S.D. The symbol ‘*’ 
documents significantly significant differences with p<0.05. 
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Figure 6. Mitochondrial DNA Content and Transcriptional Activity of 4T1 Cell 
Types. (A) 4T1, 4T1ρ0 and tumor sub-lines were evaluated for the mtDNA:nDNA ratio 
using qPCR and specific primers (Supplementary Text). The analyses were performed 
using cells maintained in culture for a short period of time (1st analysis), 1 month (2nd 
analysis) and 4 months (3rd analysis). The sub-lines were also evaluated for the level of 
RC transcripts encoded by mtDNA (B) and nDNA (C) and for transcripts of 
mitochondrial regulatory genes (D) using qPCR and specific primers (Supplementary 
Text). The data are derived from three independent experiments and the results expressed 
as mean values ± S.D. The symbol ‘*’ documents significantly significant differences 
with p<0.05. 
 
Figure 7. Mitochondrial Protein Synthesis, Respiratory Complex Formation and 
Supercomplex Assembly in 4T1 Cell Types. (A) 4T1 cells and derived sub-lines were 
evaluated for newly synthesized proteins using the Clik-iT AHA kit. The sub-lines were 
also assessed for CS (B), SDH (C) and SQR activity (D) as detailed in Materials and 
Methods, as well as expression of specific proteins using WB and specific antibodies (E). 
Tubulin was used as a loading control. (F) The mitochondrial fraction was lysed in the 
presence of digitonin and subjected to NBGE. Specific subunits of individual complexes 
were detected using the antibodies as shown. HSP60 was used as a loading control. The 
level of expression of the individual bands representing RCs, subcomplexes and SCs, was 
evaluated by densitometry relative to HSP60. The data are derived from three independent 
experiments and the results expressed as mean values ± S.D. The symbol ‘*’ documents 
significantly significant differences with p<0.05. 
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SUPPLEMENTARY TEXT 
MATERIAL AND METHODS 
Cell Culture, Tumor Formation and Establishment of Tumor-Derived Cells. B16 
and 4T1 cells were grown in the IMDM and RPMI1640 medium, respectively, containing 
10% FCS with 2 mM glutaMAX at 37ºC and 5% CO2. To delete mtDNA, cells were 
cultured for 10-12 weeks with EtBr (50-100 ng/ml) supplemented with 1 mM pyruvate 
and 50 µg/ml uridine (King and Attardi, 1989). Loss of mtDNA was monitored by 
sensitivity to 2 µM FCCP (Herst and Berridge, 2007; Herst et al, 2011), PCR analysis of 
the mitochondrial Cytb gene and by pyruvate/uridine auxotrophy. B16 and B16ρ0 cells 
(2x105) cells in HBSS were injected s.c. into the right flank of C57BL/6 or NOD/SCID 
mice. 4T1 and 4T1ρ0 cells (105) were injected either subcutaneously into the right flank 
or into the mammary fat pad of female Balb/c mice. To determine the ability of parental 
and ρ0 cells to seed and grow in the lung, 105 cells were injected intravenously. 
Animal studies were performed according to the guidelines of the Australian and 
New Zealand Council for the Care and Use of Animals in Research and Teaching and 
were approved by the local Animal Ethics Committee. 
Isolation of Mitochondria. Functional mitochondria were isolated as described (Schmitt 
et al, 2013). In brief, cells were homogenized in the isolation buffer containing 200 mM 
sucrose, 10 mM Tris-MOPS and 1 mM EGTA/Tris using the Balch homogenizer 
(Isobiotec) coupled to high-precision New Era NE-1010 pump system. Cell suspension 
containing 40-50 x 106 cells in 5 ml was passed 3 times through a 10 µm wide opening 
using a 5 ml syringe at 0.5 ml/min. The homogenate was centrifuged at 800 x g for 8 min 
at 4°C, and the supernatant containing mitochondria was further centrifuged for 15 min at 
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10,000 x g. Peletted mitochondria were re-suspended in 100-200 µl of the isolation 
buffer, and 50-100 µl of the suspension was immediately used for respiration evaluation. 
Sequence Analysis of Mitochondrial tRNAArg Gene. Total DNA was obtained from 
cells or isolated mitochondria using the Quick-gDNATM MiniPrep kit (Zymo Research) 
according to the manufacturer’s instructions. A 483 bp tRNA R region containing the 
polymorphic locus (position 9821 of reference sequence NC_005089.1) was amplified by 
PCR using a forward primer (5’-TCG ACC CTA CAA GCT CTG CAC GT-3’) and 
reverse primer (5’-TGG TGA TGG GGA TTG GTA TGG AGC-3’). PCR was performed 
in 20 µl reaction volumes containing 500 ng sample DNA, 0.5 µM of each primer and 
iTaq DNA Polymerase, dNTP mixture and PCR buffer (Intron Biotechnology). The 
reaction conditions were: 94oC for 2 min, 35 cycles of 94oC for 20 s; 70oC for 10 s; 72oC 
for 30 s, and then 72oC for 5 min. PCR products were analyzed by 2% agarose gel 
electrophoresis and purified using UltraClean PCR Clean-Up Kit (Mo Bio Labs). 
Sequencing was performed by the Massey University Genome Service using a capillary 
ABI3730 Genetic Analyzer (Applied Biosystems). The tRNAarg gene polymorphic region 
of B16 and 4T1 cells was sequenced 8-9 times using both forward and reverse primers on 
multiple occasions over 13-14 months, while isolated mtDNA from C57BL/6, Balb/c and 
NOD/SCID mice was sequenced at least once with both forward and reverse primers to 
confirm published results (Bayona-Bafaluy et al., 2003). With cells grown in culture from 
tumors that grew from B16ρ0 and 4T1ρ0 cells the polymorphic region was sequenced 2-3 
times using both forward and reverse primers on each occasion. 
Microscopic and Flow Cytometric Cell Evaluation. For COI evaluation, cells were 
fixed with 4% formalin, permeabilized with 0.2% Triton X-100 and incubated for 1 h 
with monoclonal anti-COI IgG (Molecular Probes) followed by anti-mouse AlexaFluor 
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488 IgG (Molecular Probes) for 1 h. DAPI was used for nuclear staining. For vimentin 
and E-cadherin staining, fixed and permeabilized cells were incubated overnight with 4 
µg/ml mouse monoclonal anti-vimentin IgG (Santa Cruz) and 1 µg/ml rabbit polyclonal 
anti-E-cadherin IgG (Sigma-Aldrich) and for 3 h with anti-mouse-AlexaFluor 594 IgG 
and anti-rabbit-AlexaFluor 488 IgG (Molecular Probes), and stained with 1 µg/ml 
Hoechst 33342 (Sigma-Aldrich) to visualize nuclei. For live cell imaging of mitochondria 
and mtDNA, cells were grown in chamber slides (LabTek) and incubated for 30 min with 
100 nM MitoTracker Red (Molecular Probes) and 5 µg/ml Hoechst 33342, and 
subsequently for 4 min with 2 µg/ml EtBr. Images were captured and analyzed using the 
FV1000 confocal microscope and Fluoview software (Olympus). For flow cytometric 
quantification of mtDNA content, cultured cells were stained as above without nuclear 
staining. Mean fluorescence readings were acquired using the FACScalibur cytometer 
(BD Biosciences) and the percentage of gated cells analyzed using the FlowJo software 
version 7.6.5 (Treestar). TEM was accomplished as follows. Cells were grown on cover-
slips, fixed with 2% glutaraldehyde (Agar Scientific) and post-fixed with 1% OsO4 made 
up in Sorensen's phosphate buffer (0.1 M, pH 7.2-7.4), dehydrated, and embedded in 
Epon-Durkupan (Sigma-Aldrich). Ultrathin sections (~70-90 nm) were cut, contrasted 
with uranyl acetate (Agar Scientific), and examined in the Morgagni 268 transmission 
electron microscope (FEI) at 80 kV and in the TECNAI G2 20 LaB6 electron microscope 
(FEI) at 200 kV. Images were captured with Mega View III CCD camera (Olympus Soft 
Imaging Solutions). For statistical evaluation, 50 mitochondria per cell in 25 cells from 
each sub-line were inspected and scored for mitochondria with clearly visible cristae, 
suggestive of functional mitochondria and mitochondria with ring-like cristae, suggestive 
of dysfunctional mitochondria. 
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Evaluation of ∆Ψm and ROS. The ∆Ψm-sensitive fluorescent probe TMRM was 
utilized, and the cells evaluated by flow cytometry. The mitochondrial uncoupler FCCP 
was used as a control to determine non-specific TMRM loading. Cellular ROS were 
evaluated using the probes DCF-DA or MitoSOX. Cells were incubated with either probe 
for 10 min under normal culture conditions, harvested and fluorescence of the oxidized 
probes assessed by flow cytometry. All probes were from Sigma-Aldrich, MitoSOX from 
Molecular Probes. 
Glucose Uptake, ATP Generation and Lactate Assays. For glucose uptake, cells were 
pre-incubated in low-glucose (1 g/l) DMEM for 24 h at 37°C and 5% CO2, followed by 
15-min incubation in normal DMEM (4.5 g/l glucose) in the presence of 50 µM 2-
nitrobenzodeoxyglucose (2-NBDG; Life Technologies); glucose uptake was then 
analyzed by flow cytometry. For ATP evaluation, cells were seeded at 105 per well in 96-
well plates and intracellular levels of ATP determined using a luciferase-based assay 
(CellTiter-Glo® Luminescent Assay, Promega). Results were normalized to the total 
protein level in the cell lysate assessed in each well determined by the BCA assay. For 
lactate evaluation, cells were seeded at 105 per well in 96-well plates. Aliquots of the 
medium were used for the analysis of lactate using a colorimetric kit (Trinity Biotech) 
following 24 h incubation. Results were normalized to the total protein level in the cell 
lysate. 
Respiration Assays. Experiments evaluating intact cell respiration were performed with 
cells suspended in RPMI medium without serum. Oxygen consumption was evaluated for 
cellular ROUTINE respiration, oligomycin-inhibited LEAK respiration, FCCP-stimulated 
uncoupled respiration (ETS) and rotenone/antimycin-inhibited residual respiration 
(ROX). Respiration via mitochondrial complexes was evaluated using digitonin-
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permeabilized cells suspended in the mitochondrial respiration medium MiR06, and 
oxygen consumption was evaluated for routine respiration, CI-linked respiration, 
(CI+CII)-linked respiration, maximum uncoupled respiration, CII-linked uncoupled 
respiration as well as residual oxygen consumption. Respiration via CI and CII was 
evaluated in the presence of the proper substrates and inhibitors of the other complex. 
The results were related to the number of cells. Detailed description of the conditions is 
in the Legend to Supplementary Figures. 
mtDNA Level Assay. Total DNA was extracted using the AquaPure Genomic DNA 
Isolation Kit (BioRad). 50 ng of DNA was diluted with water to 4.5 µl, and 0.5 µl of the 
combined 10 µM forward and reverse primers added (for mtDNA, mMito1 primers for 
nDNA mB2M1 primers; see Supplementary Text for sequences) and 5 µl of 2xRT² 
SYBR® Green qPCR Mastermix (Qiagen) added. The reaction was run on the Eco qPCR 
System (Illumina) with the following setting: one cycle of 50°C for 2 min; one cycle of 
95°C for 10 min; 40 cycles of 95°C for 15 s and 60°C for 1 min. 
PCR Analysis of Mitochondrial Cytb Gene. DNA was purified from 106 cells using the 
Quick-gDNA™ MiniPrep (Zymo Research), and each sample analyzed by PCR using the 
Cytb gene as a mtDNA marker with forward primer (5’-TCC TTC ATG TCG GAC GAG 
GCT-3’) and reverse primer (5’-ACG ATT GCT AGG GCC GCG AAT-3’). PCR was 
carried out in a BioRad iCycler for 30 cycles of 20 s at 94ºC, 20 s at 58ºC and 30 s at 
72ºC, and analyzed by 2% agarose gel electrophoresis. 
qPCR of mtDNA- and nDNA-Coded Genes. RNA was obtained in triplicate from 4T1- 
and 4T1ρ0- derived sub-lines using the RNeasy Mini Kit (Qiagen). The Revertaid First-
Strand Synthesis System plus random hexamer primers (Fermentas) were used to reverse-
transcribe total RNA into cDNA. Primers specific for all mitochondrial and nuclear 
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encoded genes (see Supplementary Text for sequences of primers) were then assessed 
with 2x EvaGreen (Solis BioDyne) using the Eco qPCR System. Target genes were 
normalized to the housekeeping gene GAPDH, and change in gene expression was 
determined using the ΔΔCt method. 
mtDNA isolation and sequencing. DNA was isolated from cell pellets according to 
manufacturer’s instructions using the DNAzol product (MRC). Briefly, cells were lysed 
in 1 ml of DNAzol, spun at 2,000 x g for 5 min, and the resulting supernatant precipitated 
with 0.5 ml of EtOH, spun at 14,000 x g for 10 min, and washed twice with 75% ethanol. 
the resulting pellet was air-dried and dissolved in 8 mM NaOH. The DNA preparation 
containing nDNA and mtDNA was quantified by Nanodrop and further amplified using 
mtDNA-specific primers and PCR. The full length mtDNA was covered by amplifying 
and sequencing ten 1.8 kb long dsDNA PCR products. PCR products were run on an 
agarose gel to confirm the specificity of the reaction and were purified using the DNA 
clean-and-concentrator kit (Zymoresearch). 200 to 400 ng of the purified products was 
combined with water and 0.5 µl of 100 µM primer stocks to yield 10 µl sequencing 
reaction mixture. Sequencing was performed by the GACT Biotech by the classical 
Sanger sequencing, and the resulting sequences aligned using the SeqManPro suite from 
the DNASTAR Lasergene 11 software. 
Native Blue Gel Eletrophoresis (NBGE). NBGE was accomplished basically as 
published (Wittig et al., 2006). In brief, mitochondria were isolated using a standard 
protocol. Digitonin-solublized mitochondria were separated on NativePAGE Novex Bis-
Tris 3-12% gradient gels for CI and 4-16% gradient gels for CII, CIII, CIV and CV. After 
electrophoresis, the gels were incubated in the SDS-PAGE running buffer for 5 min and 
proteins transferred to PVDF membranes probed with specific antibodies against 
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complex I (NUDFA9), CII (SDHA or SDHB), CIII (CORE2), CIV (COVa) and CV 
(ATPaseβ) and HSP60 as the loading control. 
Western Blotting. Cells were lysed in the RIPA buffer supplemented with the Complete 
Protease Inhibitor Cocktail (Roche). The lysate was cleared by centrifugation and total 
protein determined. 40 µg of total protein were resolved by SDS-PAGE and transferred 
to nitrocellulose membranes, which were then probed with appropriate antibodies 
(NDUFS3, NDUFA9, SDHA, SDHB, Core2, COI, COIV, ATPaseβ, PGCα, TIM23, 
VDAC, OPA1, Parkin, BNIP3 and HSP60 were from Abcam, SDHFA2 from Santa Cruz, 
SOD2 from Acris Antibodies, Cyt c from BD Pharmingen, LC3BI/II form Cell Signaling, 
tubulin from Exbio, and actin from Sigma-Aldrich). The blotted proteins reacted with 
specific antibodies were detected using the ECL Western Blotting Substrate (Pierce). 
In vitro Translation of mtDNA-Encoded Genes. Newly synthesized mtDNA-encoded 
proteins were evaluated in intact cells using the Clik-iT AHA kit (Invitrogen). Briefly, 
cells were incubated with methionine-free RPMI for 10 min at 37°C and 5% CO2 and 
subsequently with 100 µg/ml cyclohexamide. After 30 min, 3 mM L-azidohomoalanine 
(azhal, a methionine analog) was added and the cells incubated for 2 h. Azhal-labeled 
cells were harvested and the total cellular protein extracted in 20 mM Tris-HCl pH 8.0, 
1% SDS and 250 U/ml benzonase nuclease (Sigma-Aldrich). The cyclo-addition of 
alkyne-tagged TAMRA to azhal-labeled proteins was carried out according to the 
manufacturer’s protocol. Proteins were separated by Tris-Tricine SDS-PAGE and 
transferred to a PVDF membrane, and mitochondrial translation products detected with 
anti-TAMRA IgG (Abcam). Total protein stained with Commassie Blue was used as a 
loading control. 
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CS, SDH and SQR Activity Assays. CS activity was assessed by the reduction of 5,5′-
dithiobis-(2-nitrobenzoic acid) (DTNB) using the coupled reaction with acetyl-CoA and 
oxaloacetate. In brief, 10 µg of protein lysate were added to 10 µM DTNB and 30 µM 
acetyl-CoA and the reaction initiated by adding 10 µM oxaloacetate in a 200 µl reaction 
mixture. The change in absorbance of DTNB was assessed spectrophotometrically for 90 
s at 412 nm and 30ºC, and the activity calculated as described (Shephard and Garland, 
1969). Purified CS was used as positive control. For SQR activity, 40 µg of protein lysate 
extracted before the assay (Cell Lysis Buffer, Cell Signaling) were added to 1 ml of the 
SQR assay buffer (10 mM KH2PO4, pH 7.8, 2 mM EDTA, 1 mg/ml BSA), 80 µM 
DCPIP, 4 µM rotenone, 0.2 mM ATP and10 mM succinate, and incubated at 30ºC for 10 
min. Decylubiquinone was added to a final concentration of 80 µM, and absorbance 
assessed every minute for 30 min at 600 nm (Barrientos et al., 2009). SDH activity was 
assessed as described (Dong et al., 2008). 
 
Primers Used for qPCR Analysis of mtDNA- and nDNA-Coded Genes 
Gene Forward Reverse 
mMito1 CTA GAA ACC CCG AAA CCA AA CCA GCT ATC ACC AAG CTC GT 
mB2M1 ATG GGA AGC CGA ACA TAC TG CAG TCT CAG TGG GGG TGA AT 
D-Loop AGG TTT GGT CCT GGC CTT AT GTG GCT AGG CAA GGT GTC TT 
12S CTA GCC ACA CCC CCA CGG GA CGT ATG ACC GCG GTG GCT GG 
16S CGG CAA ACA AGA ACC CCG CC GTC AGG ATA CCG CGG CCG TT 
Nd1 CAG CCG GCC CAT TCG CGT TA AGC GGA AGC GTG GAT AGG ATG C 
Nd2 TCC TCC TGG CCA TCG TAC TCA ACT AGA AGT GGA ATG GGG CGA GGC 
Nd3 
ACC CTA CAA GCT CTG CAC GCC 
GCT CAT GGT AGT GGA AGT AGA AGG 
GCA 
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Nd4 TCG CCT ACT CCT CAG TTA GCC ACA TGA TGA TGT GAG GCC ATG TGC GA 
Nd4l TCG CTC CCA CCT AAT ATC CAC ATT 
GC 
GCA GGC TGC GAA AAC CAA GAT GG 
Nd5 TCG GAA GCC TCG CCC TCA CA AGT AGG GCT CAG GCG TTG GTG T 
Nd6 AAT ACC CGC AAA CAA AGA TCA CCC 
AG 
TGT TGG GGT TAT GTT AGA GGG AGG 
GA 
Ndufs3 TGG CAG CAC GTA AGA AGG G CTT GGG TAA GAT TTC AGC CAC AT 
Sdha GGA ACA CTC CAA AAA CAG ACC T CCA CCA CTG GGT ATT GAG TAG AA 
Sdhb AAT TTG CCA TTT ACC GAT GGG A AGC ATC CAA CAC CAT AGG TCC 
Sdhc GTT CTT GCT GAG ACA TGT CA AGT GAG TGG TAC ATG AGC 
Sdhd TGG TCA GAC CCG CTT ATG TG GGT CCA GTG GAG AGA TGC AG 
Cytb ACA CGC AAA CGG AGC CTC AA TGC TGT GGC TAT GAC TGC GAA CA 
Uqcrc2 AAA GTT GCC CCG AAG GTT AAA GAG CAT AGT TTT CCA GAG AAG CA 
mt-Co1 CCA GTG CTA GCC GCA GGC AT TCT GGG TGC CCA AAG AAT CAG AAC A 
mt-Co2 AGT TGA TAA CCG AGT CGT TCT GCC 
A 
TCG GCC TGG GAT GGC ATC AGT 
mt-Co3 ACC TAC CAA GGC CAC CAC ACT CC GCA GCC TCC TAG ATC ATG TGT TGG T 
mt-CO4 ATT GGC AAG AGA GCC ATT TCT AC CAC GCC GAT CAG CGT AAG T 
Atp6 GCT CAC TCG CCC ACT TCC TTC C GCC GGA CTG CTA ATG CCA TTG GTT 
Atp8 ATG CCA CAA CTA GAT ACA TCA ACA GGG GTA ATG AAT GAG GCA AA 
Atp5b GGT TCA TCC TGC CAG AGA CTA AAT CCC TCA TCG AAC TGG ACG 
Top1m GGG ATT CCA AGA TCC CTG AC ATC TTG TCC ACA ACC CCC TT 
Nrf1 ACT CAG CCA CGT TGG ATG GAG GCG GCA GCT CTG AAT TA 
Nrf2 ATG ATG GAC TTG GAG TTG CCA GCT CAT AGT CCT TCT GTC GC 
Tfam GGC AAA GGA TGA TTC GGC TC CAC TTC GTC CAA CTT CAG CC 
Tfb1m GAC TGC GAG CGG TGA AAC AG CCT GGG ATA AAG CGA GTG T 
Tfb2m GCC AAT TGC TTG CAT CTC CC ACA AGG CCT GGG ACT TAT GC 
Scaf1 GCA GAA GTT TTT CA GAA GGC T GGG CGA TCA GGC AGT AGA TG 
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Hig2a CCC CAG TTA TCG AGG GCT TC CCG TCC CCA GAC AGC CTA T 
Gapdh ACA GCC GCA TCT TCT TGT GCA GTG GGC CTT GAC TGT GCC GTT GAA TTT 
 
 
LEGEND TO SUPPLEMENTARY FIGURES 
 
Figure S1. Tumor-forming Ability of 4T1ρ0 Cells 
4T1ρ0 cells (105, 104,103,102) were injected s.c. into groups of 5 Balb/c mice and tumor 
growth monitored every 2 days. 
 
Figure S2. ‘Matching’ 4T1 Tumor Cells Do Not Differ in Morphology 
(A) 4T1, 4T1SC and 4T1SCL cells were grown to 70% confluency, stained with EtBr 
and MitoTracker Red, and inspected by confocal microscopy showing the individual 
channels as well as their overlay (including nuclear staining with Hoechst 33342). Cells 
stained in a corresponding manner with EtBr and MitoTracker Red were evaluated using 
flow cytometry to reveal the percentage of mitochondria with and without DNA. (B) 
Cells were subjected to TEM and inspected for mitochondrial morphology. 
 
Figure S3. ‘Matching’ Tumor Cells Show Similar Characteristics Relating to Their 
Mitochondrial Function. 4T1, 4T1SC and 4T1SCL cells were grown and assessed, as 
detailed in Materials and Methods, for glucose uptake (A), lactate release (B), ATP 
generation (C), ROS generation using the MitoSOX (D) and DCF (E) probe, routine 
respiration using the Oxygraph (F), mtDNA:nDNA ratio by qPCR (G), expression of 
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mitochondria regulatory genes by qPCR (H), CS (I), SDH (J) and SQR activities (K), and 
protein expression using WB (L). 
 
Figure S4. Mitochondrial ROS Production by Tumor Cells Derived from 
Mitochondrially-Defective ρ0 Cells. (A) Mitochondrial oxidant production by 4T1 and 
4T1ρ0 cells, and 6TG-resistant cells from primary subcutaneous (4T1ρ0SC) and 
orthotopic (4T1ρ0MFP) tumors that grew from 4T1ρ0 cells, and from lung metastases 
(4T1ρ0SCL and 4T1ρ0MFPL) from these primary tumors (left 6 panels), and (B) by B16 
and B16ρ0 cells and cells from primary subcutaneous (B16ρ0SC) and lung metastases 
(B16ρ0SCL (right panels) used MitoSOX staining. 
 
Figure S5. Primary Data on Mitochondrial Respiration in 4T1 Cell Lines 
(A) 4T1, 4T1ρ0, 4T1ρ0SC, 4T1ρ0CTC and 4T1ρ0SCL cells were plated and, when 
reaching 50-70% confluency, harvested and evaluated for routine (R), leak (L), net (R-L) 
and uncoupled (E) and residual (ROX) respiration using the Oxygraph respiratometer as 
described in more detail in Materials and Methods. (B) 4T1, 4T1ρ0SC, 4T1ρ0CTC and 
4T1ρ0SCL cells were plated and, when reaching 50-70% confluency harvested, 
permeabilized with digitonin and evaluated for respiration at the presence of substrates 
specific for CI and CII using the protocol indicated in more detail in Materials and 
Methods. The lower panels document representative evaluations of the respiration curves, 
indicating the ‘leak’, respiration via CI, CI+CII, uncoupled respiration via CI+CII (ETC) 
plus uncoupled respiration via CII. The residual respiration (ROX) was set to zero. The 
abbreviations in the top left line graphs in panels A and B are: Omy, 0.5 µM oligomycin; 
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F1, 1 µM FCCP; Rot, 0.1-0.5 µM rotenone; Dig, 10 µg digitonine per 106 cells; PMG, 5 
mM pyruvate; 2 mM malate; 10 mM glutamate; ADP, 1-5 µM ADP; cyt c, 10 µM Cyt c; 
succ, 10 mM. (C) Mitochondria isolated from individual 4T1 sub-lines were assessed for 
respiration as mentioned above for permeabilized cells.
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Supplementary Table I.  Polymorphisms in 4T1 and B16 mtDNA confirm host 
origin of mtDNA in tumors derived from ρ0 cells 
 
Site Base in Balb/c 
(reference*) 
Base in 
4T1ρ0SC 
cells 
Base in 
4T1 cells 
Gene 
1574 T T C 16S rRNA 
9829 A A - tRNAArg 
16076 A A G D-Loop 
 
 
Site Base in C57BL/6 
(reference*) 
Base in 
B16ρ0SC 
cells 
Base in 
B16 cells 
  Gene 
9821 - - A+    tRNAArg 
9829 - - -    tRNAArg 
1035 C C T    Nd4 
 
             * see Bayona-Bafaluy e al 2003 and NC_005089.1 
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